Cargando…

Single Administration of the T-Type Calcium Channel Enhancer SAK3 Reduces Oxidative Stress and Improves Cognition in Olfactory Bulbectomized Mice

Alzheimer’s disease (AD), characterized by cognitive impairments, is considered to be one of the most widespread chronic neurodegenerative diseases worldwide. We recently introduced a novel therapeutic agent for AD treatment, the T-type calcium channel enhancer ethyl-8-methyl-2,4-dioxo-2-(piperidin-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yuan, Dian, Cheng, An, Kawahata, Ichiro, Izumi, Hisanao, Xu, Jing, Fukunaga, Kohji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7828528/ https://www.ncbi.nlm.nih.gov/pubmed/33451040 http://dx.doi.org/10.3390/ijms22020741

Ejemplares similares

T-Type Ca(2+) Enhancer SAK3 Activates CaMKII and Proteasome Activities in Lewy Body Dementia Mice Model
por: Xu, Jing, et al.
Publicado: (2021)

SAK3 Administration Improves Spine Abnormalities and Cognitive Deficits in App(NL-G-F/NL-G-F) Knock-in Mice by Increasing Proteasome Activity through CaMKII/Rpt6 Signaling
por: Izumi, Hisanao, et al.
Publicado: (2020)

T-type calcium channel enhancer SAK3 promotes dopamine and serotonin releases in the hippocampus in naive and amyloid precursor protein knock-in mice
por: Wang, Shuo, et al.
Publicado: (2018)

PT562. Alzheimer disease therapeutics candidate, SAK3 improves the cognitive functions through inhibition of amyloid beta accumulation in APP23 mice.
por: Izumi, ○Hisanao, et al.
Publicado: (2016)

Correction: T-type calcium channel enhancer SAK3 promotes dopamine and serotonin releases in the hippocampus in naive and amyloid precursor protein knock-in mice
por: Wang, Shuo, et al.
Publicado: (2019)

Evaluation of the effects of the T-type calcium channel enhancer SAK3 in a rat model of TAF1 deficiency
por: Dhanalakshmi, Chinnasamy, et al.
Publicado: (2020)

Stimulation of the Sigma-1 Receptor by DHEA Enhances Synaptic Efficacy and Neurogenesis in the Hippocampal Dentate Gyrus of Olfactory Bulbectomized Mice
por: Moriguchi, Shigeki, et al.
Publicado: (2013)

Correction: Stimulation of the Sigma-1 Receptor by DHEA Enhances Synaptic Efficacy and Neurogenesis in the Hippocampal Dentate Gyrus of Olfactory Bulbectomized Mice
por: Moriguchi, Shigeki, et al.
Publicado: (2014)

Simvastatin improves learning and memory in control but not in olfactory bulbectomized rats
por: Douma, Tessa N., et al.
Publicado: (2011)

Restoration of Serotonin Neuronal Firing Following Long-Term Administration of Bupropion but Not Paroxetine in Olfactory Bulbectomized Rats
por: Mansari, Mostafa El, et al.
Publicado: (2015)

Ameliorative Effects of Acanthopanax trifoliatus on Cognitive and Emotional Deficits in Olfactory Bulbectomized Mice: An Animal Model of Depression and Cognitive Deficits
por: Sithisarn, Pongtip, et al.
Publicado: (2013)

Hippocampus Metabolic Disturbance and Autophagy Deficiency in Olfactory Bulbectomized Rats and the Modulatory Effect of Fluoxetine
por: Zhou, Yunfeng, et al.
Publicado: (2019)

Anti-Epileptic Effects of FABP3 Ligand MF1 through the Benzodiazepine Recognition Site of the GABA(A) Receptor
por: Yabuki, Yasushi, et al.
Publicado: (2020)

Sak and Sak4 recombinases are required for bacteriophage replication in Staphylococcus aureus
por: Neamah, Maan M., et al.
Publicado: (2017)

Scabronine G Methyl Ester Improves Memory-Related Behavior and Enhances Hippocampal Cell Proliferation and Long-Term Potentiation via the BDNF-CREB Pathway in Olfactory Bulbectomized Mice
por: Nakagawasai, Osamu, et al.
Publicado: (2020)

Sex and Feeding Status Differently Affect Natural Reward Seeking Behavior in Olfactory Bulbectomized Rats
por: Ruda-Kucerova, Jana, et al.
Publicado: (2018)

Self-microemulsifying drug delivery system (SMEDDS) of curcumin attenuates depression in olfactory bulbectomized rats
por: Aswar, Manoj, et al.
Publicado: (2020)

High-frequency ultrasound exposure improves depressive-like behavior in an olfactory bulbectomized rat model of depression
por: Yamauchi, Tsugumi, et al.
Publicado: (2022)

Ocimum sanctum Linn. Extract Improves Cognitive Deficits in Olfactory Bulbectomized Mice via the Enhancement of Central Cholinergic Systems and VEGF Expression
por: Le, Xoan Thi, et al.
Publicado: (2021)

Degradation of Tyrosine Hydroxylase by the Ubiquitin-Proteasome System in the Pathogenesis of Parkinson’s Disease and Dopa-Responsive Dystonia
por: Kawahata, Ichiro, et al.
Publicado: (2020)

Protein Kinases and Neurodegenerative Diseases
por: Kawahata, Ichiro, et al.
Publicado: (2023)

Effects of 4-hydroxyisoleucine from Fenugreek Seeds on Depression-like Behavior in Socially Isolated Olfactory Bulbectomized Rats
por: Kalshetti, Padmaja B., et al.
Publicado: (2015)

Enhanced self-administration of the CB(1) receptor agonist WIN55,212-2 in olfactory bulbectomized rats: evaluation of possible serotonergic and dopaminergic underlying mechanisms
por: Amchova, Petra, et al.
Publicado: (2014)

Fatty Acid Binding Protein 5 Mediates Cell Death by Psychosine Exposure through Mitochondrial Macropores Formation in Oligodendrocytes
por: Cheng, An, et al.
Publicado: (2020)

Saks spaces and applications to functional analysis
por: Cooper, James Bell
Publicado: (1978)

Immunization Against Specific Fragments of Neurotrophin p75 Receptor Protects Forebrain Cholinergic Neurons in the Olfactory Bulbectomized Mice
por: Bobkova, Natalia, et al.
Publicado: (2016)

Epidermal Fatty Acid-Binding Protein 5 (FABP5) Involvement in Alpha-Synuclein-Induced Mitochondrial Injury under Oxidative Stress
por: Wang, Yifei, et al.
Publicado: (2021)

Neuropeptide Trefoil Factor 3 Reverses Depressive-Like Behaviors by Activation of BDNF-ERK-CREB Signaling in Olfactory Bulbectomized Rats
por: Li, Jiali, et al.
Publicado: (2015)

The Role of CaMKII and ERK Signaling in Addiction
por: Jia, Wenbin, et al.
Publicado: (2021)

A novel fatty acid-binding protein 5 and 7 inhibitor ameliorates oligodendrocyte injury in multiple sclerosis mouse models
por: Cheng, An, et al.
Publicado: (2021)

Impact of Fatty Acid-Binding Proteins in α-Synuclein-Induced Mitochondrial Injury in Synucleinopathy
por: Cheng, An, et al.
Publicado: (2021)

Pathogenic Impact of α-Synuclein Phosphorylation and Its Kinases in α-Synucleinopathies
por: Kawahata, Ichiro, et al.
Publicado: (2022)

Expression of Concern: Stimulation of the Sigma-1 Receptor by DHEA Enhances Synaptic Efficacy and Neurogenesis in the Hippocampal Dentate Gyrus of Olfactory Bulbectomized Mice
Publicado: (2023)

Fatty Acid-Binding Protein 3 is Critical for α-Synuclein Uptake and MPP(+)-Induced Mitochondrial Dysfunction in Cultured Dopaminergic Neurons
por: Kawahata, Ichiro, et al.
Publicado: (2019)

Involvement of NMDA-AKT-mTOR Signaling in Rapid Antidepressant-Like Activity of Chaihu-jia-Longgu-Muli-tang on Olfactory Bulbectomized Mice
por: Wang, Xing, et al.
Publicado: (2019)

Expression of Concern: T-type calcium channel enhancer SAK3 promotes dopamine and serotonin releases in the hippocampus in naive and amyloid precursor protein knock-in mice
Publicado: (2023)

Treadmill exercise improves depression-like symptoms by enhancing serotonergic function through upregulation of 5-HT(1A) expression in the olfactory bulbectomized rats
por: Shin, Mal-Soon, et al.
Publicado: (2017)

Plk4/SAK/ZYG-1 in the regulation of centriole duplication
por: Pearson, Chad G, et al.
Publicado: (2010)

Using Fatty Acid-Binding Proteins as Potential Biomarkers to Discriminate between Parkinson’s Disease and Dementia with Lewy Bodies: Exploration of a Novel Technique
por: Kawahata, Ichiro, et al.
Publicado: (2023)

Fatty Acid-Binding Proteins: Their Roles in Ischemic Stroke and Potential as Drug Targets
por: Guo, Qingyun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_bpolkojasqkq6hqa7i9lgvccl8